Cargando…

Cost effectiveness analyses of pharmacological treatments in heart failure

In a rapidly growing and aging population, heart failure (HF) has become recognised as a public health concern that imposes high economic and societal costs worldwide. HF management stems from the use of highly cost-effective angiotensin converting enzyme inhibitors (ACEi) and β-blockers to the use...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Audrey Huili, Abdul Rahim, Nusaibah, Zhao, Jinxin, Cheung, S. Y. Amy, Lin, Yu-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483981/ https://www.ncbi.nlm.nih.gov/pubmed/36133814 http://dx.doi.org/10.3389/fphar.2022.919974

Ejemplares similares

Optimizing Antimicrobial Therapy by Integrating Multi-Omics With Pharmacokinetic/Pharmacodynamic Models and Precision Dosing
por: Yow, Hui-Yin, et al.
Publicado: (2022)

Editorial: Model-informed drug development and evidence-based translational pharmacology
por: Zhao, Jinxin, et al.
Publicado: (2022)

Cost-effectiveness of empagliflozin for the treatment of heart failure: a systematic review
por: Liu, Jinyu, et al.
Publicado: (2023)

In silico genome-scale metabolic modeling and in vitro static time-kill studies of exogenous metabolites alone and with polymyxin B against Klebsiella pneumoniae
por: Chung, Wan Yean, et al.
Publicado: (2022)

Pharmacological Insights Into Safety and Efficacy Determinants for the Development of Adenosine Receptor Biased Agonists in the Treatment of Heart Failure
por: Rueda, Patricia, et al.
Publicado: (2021)

Mechanism and Protective Effect of Smilax glabra Roxb on the Treatment of Heart Failure via Network Pharmacology Analysis and Vitro Verification
por: Long, Yingxin, et al.
Publicado: (2022)

Pharmacological Tuning of Adenosine Signal Nuances Underlying Heart Failure With Preserved Ejection Fraction
por: Campos-Martins, Alexandrina, et al.
Publicado: (2021)

Efficacy of pharmacologic therapies in patients with acute heart failure: A network meta-analysis
por: Dai, Hengheng, et al.
Publicado: (2022)

The mechanism of Renshen-Fuzi herb pair for treating heart failure—Integrating a cardiovascular pharmacological assessment with serum metabolomics
por: Chen, Xiaofei, et al.
Publicado: (2022)

Metabolic and Network Pharmacological Analyses of the Therapeutic Effect of Grona styracifolia on Calcium Oxalate-Induced Renal Injury
por: Chen, Wei, et al.
Publicado: (2021)

Comparison of Pharmacological Treatment Effects on Long-Time Outcomes in Heart Failure With Preserved Ejection Fraction: A Network Meta-analysis of Randomized Controlled Trials
por: Lin, Yaowang, et al.
Publicado: (2021)

Cost-utility analysis of empagliflozin in heart failure patients with reduced and preserved ejection fraction in China
por: Tang, Yi, et al.
Publicado: (2022)

Editorial: Recent trends in pharmacological treatment of musculoskeletal disorders
por: Zong, Zhixian, et al.
Publicado: (2022)

Cost-Effectiveness of Adding SGLT2 Inhibitors to Standard Treatment for Heart Failure With Reduced Ejection Fraction Patients in China
por: Jiang, Yaohui, et al.
Publicado: (2021)

Sacubitril–valsartan versus enalapril for the treatment of acute decompensated heart failure in Chinese settings: A cost-effectiveness analysis
por: Hu, Tianyang, et al.
Publicado: (2023)

Factors Associated With Hospital Readmission of Heart Failure Patients
por: Al-Tamimi, Maitha Abdul-Aziz, et al.
Publicado: (2021)

Therapeutic mechanism of Curcuma aromatica Salisb. rhizome against coronary heart disease based on integrated network pharmacology, pharmacological evaluation and lipidomics
por: Fei, Chenghao, et al.
Publicado: (2022)

Trimetazidine in Heart Failure
por: Shu, Hongyang, et al.
Publicado: (2021)

Rhein for treating diabetes mellitus: A pharmacological and mechanistic overview
por: Deng, Tingting, et al.
Publicado: (2023)

Mechanisms and Efficacy of Traditional Chinese Medicine in Heart Failure
por: Wang, Anzhu, et al.
Publicado: (2022)

Prevention of Surgical Site Infections: A Systematic Review of Cost Analyses in the Use of Prophylactic Antibiotics
por: Purba, Abdul K. R., et al.
Publicado: (2018)

SGLT2 inhibitors for patients with heart failure with preserved ejection fraction in China: a cost-effectiveness study
por: Lu, He, et al.
Publicado: (2023)

Screening of anti-heart failure active compounds from fangjihuangqi decoction in verapamil-induced zebrafish model by anti-heart failure index approach
por: Li, Jun, et al.
Publicado: (2022)

Integrating Network Pharmacology and Pharmacological Evaluation for Deciphering the Action Mechanism of Herbal Formula Zuojin Pill in Suppressing Hepatocellular Carcinoma
por: Guo, Wei, et al.
Publicado: (2019)

The Mechanism Actions of Astragaloside IV Prevents the Progression of Hypertensive Heart Disease Based on Network Pharmacology and Experimental Pharmacology
por: Jing, Haoran, et al.
Publicado: (2021)

Investigating the Pharmacological Mechanisms of SheXiang XinTongNing Against Coronary Heart Disease Based on Network Pharmacology and Experimental Evaluation
por: Jia, Li-ying, et al.
Publicado: (2021)

CTRP5-Overexpression Attenuated Ischemia-Reperfusion Associated Heart Injuries and Improved Infarction Induced Heart Failure
por: Peng, Meng, et al.
Publicado: (2020)

Clinical Efficacy and Safety of Xinmailong Injection for the Treatment of Chronic Heart Failure: A Meta-Analysis
por: Lu, Xiaohua, et al.
Publicado: (2018)

The Role of Myocardial Mitochondrial Quality Control in Heart Failure
por: Qiu, Zhiling, et al.
Publicado: (2019)

Immunomodulatory Treatment Strategies Targeting B Cells for Heart Failure
por: Zhang, Xinxin, et al.
Publicado: (2022)

Cell-Based Therapies for Heart Failure
por: Campos de Carvalho, Antonio Carlos, et al.
Publicado: (2021)

Implementing Clinical Decision Support Tools and Pharmacovigilance to Reduce the Use of Potentially Harmful Medications and Health Care Costs in Adults With Heart Failure
por: Silva Almodóvar, Armando, et al.
Publicado: (2021)

Cost-effectiveness of adding empagliflozin to the standard of care for patients with heart failure with reduced ejection fraction from the perspective of healthcare system in Malaysia
por: Ong, Siew Chin, et al.
Publicado: (2023)

Wenxin Keli for the Treatment of Arrhythmia—Systems Pharmacology and In Vivo Pharmacological Assessment
por: Li, Xiaofeng, et al.
Publicado: (2021)

An Integrative Pharmacology-Based Pattern to Uncover the Pharmacological Mechanism of Ginsenoside H Dripping Pills in the Treatment of Depression
por: Zhao, Libin, et al.
Publicado: (2021)

Pharmacological Blockade of Soluble Epoxide Hydrolase Attenuates the Progression of Congestive Heart Failure Combined With Chronic Kidney Disease: Insights From Studies With Fawn-Hooded Hypertensive Rats
por: Vacková, Šárka, et al.
Publicado: (2019)

Cyclic GMP and PKG Signaling in Heart Failure
por: Numata, Genri, et al.
Publicado: (2022)

Risk of Heart Failure Hospitalization Associated With Cilostazol in Diabetes: A Nationwide Case–Crossover Study
por: Wu, Cho-Kai, et al.
Publicado: (2019)

Network pharmacology-based prediction of active compounds in the Wenyang Jiedu Huayu formula acting on acute-on-chronic liver failure with experimental support in vitro and in vivo
por: Tang, Dan, et al.
Publicado: (2022)

Traditional Chinese medicine for heart failure with preserved ejection fraction: clinical evidence and potential mechanisms
por: Fan, Yujian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_548ka7ij2bdb8vmeui4nc3k4lu